📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nexstim

1.1 - Company Overview

Nexstim Logo

Nexstim

Headquarter: Finland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of image-guided transcranial magnetic stimulation solutions, including SmartFocus nTMS for precise targeting in treating major depressive disorder and for pre-surgical brain mapping; NBS System 5 for navigated mapping of speech and motor cortices (FDA approval, CE marking); and NBS System 6 for major depressive disorder and chronic neuropathic pain (FDA clearance, CE marking; available in the US and Europe).

Products and services

  • SmartFocus® nTMS: An image-guided, non-invasive brain stimulation product engineered for precise targeting in treating major depressive disorder and supporting pre-surgical brain mapping applications
  • NBS System 6: An FDA-cleared therapeutic system designed for treating major depressive disorder and chronic neuropathic pain, available in the United States and Europe with CE marking
  • NBS System 5: A navigated brain stimulation system for pre-surgical mapping of speech and motor cortices, backed by FDA approval and CE marking.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nexstim

SwanBio Therapeutics Logo

SwanBio Therapeutics

HQ: United States Website
  • Description: Provider of gene therapy focused on genetically defined therapies for neurological disorders. Offerings include SBT101, a candidate for adrenomyeloneuropathy targeting ABCD1 via AAV9; pipeline development in spinal cord-related indications; clinical trials, including a Phase 1/2 study of SBT101 and natural history studies of AMN; and patient and family resources, including trial information and compassionate use policies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SwanBio Therapeutics company profile →
Oculogica Logo

Oculogica

HQ: United States Website
  • Description: Provider of neuro-diagnostic medical devices and training focused on TBI, concussion, and eye-tracking. Products include EyeBOX, an FDA-cleared, baseline-free, non-invasive device that tracks eye movements to aid in concussion (mTBI) diagnosis with results in under four minutes, and OcuPro, a roadside test for law enforcement to detect recent cannabis use and impairment. Offers EyeBOX training to customers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oculogica company profile →
CereVasc Logo

CereVasc

HQ: United States Website
  • Description: Provider of endovascular medical devices for treating hydrocephalus, including the eShunt System—an endovascularly implantable cerebrospinal fluid shunt with delivery components designed to treat communicating hydrocephalus without invasive surgery—and a portfolio of follow-on product concepts to improve care for neurovascular diseases, including therapies deliverable across the blood-brain barrier.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CereVasc company profile →
Rapid Dose Therapeutics Logo

Rapid Dose Therapeutics

HQ: Canada Website
  • Description: Provider of pharma-tech oral fast-dissolving drug delivery solutions, including QuickStrip for direct bloodstream delivery of pharmaceuticals and over-the-counter medicines; RDMx + QuickStrip for enabling delivery of large therapeutic molecules; Rapid Energy, Vitamin B12, and Melatonin QuickStrip products; and versions for elderly and pediatric patients needing simplified, rapid dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rapid Dose Therapeutics company profile →
Oligomerix Logo

Oligomerix

HQ: United States Website
  • Description: Provider of target identification and validation technologies to enhance drug discovery for neurodegenerative diseases, and tau-targeting therapeutics including OLX-07010, a Phase 1 small molecule inhibitor of tau self-association, a series of tau small molecule inhibitors, and companion biomarker programs to aid diagnosis and monitoring.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oligomerix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nexstim

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nexstim

2.2 - Growth funds investing in similar companies to Nexstim

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nexstim

4.2 - Public trading comparable groups for Nexstim

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nexstim

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nexstim

What does Nexstim do?

Nexstim is a provider of image-guided transcranial magnetic stimulation solutions, including SmartFocus nTMS for precise targeting in treating major depressive disorder and for pre-surgical brain mapping; NBS System 5 for navigated mapping of speech and motor cortices (FDA approval, CE marking); and NBS System 6 for major depressive disorder and chronic neuropathic pain (FDA clearance, CE marking; available in the US and Europe).

Who are Nexstim's competitors?

Nexstim's competitors and similar companies include SwanBio Therapeutics, Oculogica, CereVasc, Rapid Dose Therapeutics, and Oligomerix.

Where is Nexstim headquartered?

Nexstim is headquartered in Finland.

How many employees does Nexstim have?

Nexstim has 1,000 employees 🔒.

When was Nexstim founded?

Nexstim was founded in 2010 🔒.

What sector and industry vertical is Nexstim in?

Nexstim is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nexstim

Who are the top strategic acquirers in Nexstim's sector and industry

Top strategic M&A buyers and acquirers in Nexstim's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nexstim?

Top strategic M&A buyers groups and sectors for Nexstim include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nexstim's sector and industry vertical

Which are the top PE firms investing in Nexstim's sector and industry vertical?

Top PE firms investing in Nexstim's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nexstim's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nexstim's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nexstim's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nexstim include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nexstim's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nexstim?

The key public trading comparables and valuation benchmarks for Nexstim include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nexstim for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nexstim with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nexstim's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nexstim with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nexstim's' sector and industry vertical?

Access recent funding rounds and capital raises in Nexstim's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nexstim